On Friday, Following U.S. Stocks were among the “Top Losers”: Xenia Hotels & Resorts, Inc (NYSE:XHR), Precision Castparts Corp (NYSE:PCP), XOMA Corp (NASDAQ:XOMA), KBR, Inc (NYSE:KBR)
Xenia Hotels & Resorts, Inc (NYSE:XHR)’s shares dwindled -2.57%, and closed at $22.00. The company has the market capitalization of $2.52B. In the last trading session 1.76M shares changed hands as compared to its average volume of 1.14M shares. On the other hand the stock’s volatility for the week is 4.03%, and for the month is 2.81%.
Xenia Hotels & Resorts, Inc. operates as a self-advised and self-administered REIT that invests in full service hotels. As of September 30, 2014, it owned 46 hotels comprising 12,636 rooms across 19 states and the District of Columbia, and had interests in 2 hotels under development. The company is based in Orlando, Florida.
Precision Castparts Corp (NYSE:PCP), declined -2.55%, and closed at $204.59. The stock has the beta value of 0.99, and its volatility for the week is 1.40%, while for the month it is 1.62%. The company has the market capitalization of $29.00B. The company holds the book value per share of 82.83, whereas cash per share is 3.03. Price to book value is estimated to be 2.47, while price to sale value is 2.89. Analysts mean recommendation for the stock is said to be 2.10 (where 1=Buy, 5=sale).
Precision Castparts Corp. manufactures and sells metal components and products worldwide. It operates in three segments: Investment Cast Products, Forged Products, and Airframe Products. The Investment Cast Products segment manufactures investment castings for aircraft engines, industrial gas turbine (IGT) engines, airframes, medical implants, armament, unmanned aerial vehicles, and other industrial applications. This segment provides aerospace structural castings; aerospace airfoil castings, such as stationary vanes and rotating blades; IGT castings, in addition to structural and airfoil castings for aero derivative gas turbine engines; other investment casting products, counting artificial hips and knees, landing gear struts, and engine inlets for unmanned aerial vehicles, in addition to impellers for pumps and compressors; and titanium components for armament systems.
XOMA Corp (NASDAQ:XOMA), dipped -2.51%, and closed at $3.68. The company holds the market capitalization of 428.15M. For the trailing twelve months, the stock’s return on assets value is -82.60%, in response to its return on investment value of -157.30%. Its 20-day moving average declined -1.56%, above 50-day moving average of 1.54%, below 200-day moving average of -11.26% from the latest market price of $3.68. The mean recommendation of analysts for this stock is 2.00.(where 1=Buy, 5=Sale).
XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. Its proprietary products comprise gevokizumab, a humanized allosteric-modulating monoclonal antibody that binds to the inflammatory cytokine interleukin-1 beta, which is in Phase III studies for non-infectious uveitis, Behet’s uveitis, pyoderma gangrenosum, active non-infectious anterior scleritis, cardiovascular disease, Schnitzler syndrome, and other diseases, in addition to diseases under the neutrophilic dermatoses designation; and various proof-of-concept studies, counting polymyositis/dermatomyositis, Schnitzler syndrome, and giant cell arteritis.
KBR, Inc (NYSE:KBR), dropped -2.46%, and closed at $14.68. The stock has price to sale value of 0.33, however, price to book value is 2.32. With recent decline, the year-to-date (YTD) performance reflected a -12.93% declined below last year. During the past month the stocks lose -45.53%, bringing three-month performance to -6.08% and six-month performance to -30.16%. The mean recommendation of analysts for this stock is 2.60. (where 1=Buy, 5=Sale).
KBR, Inc. operates as an engineering, construction, and services company worldwide. The company operates through three segments: Technology & Consulting, Engineering & Construction, and Government Services. The Technology & Consulting segment offers various services and solutions, counting licensing, engineering and design, proprietary equipment, plant automation, catalysts, and related consulting services to hydrocarbons, chemicals, and fertilizer markets. This segment provides field development and planning, technology selection and optimization of capital spending, offshore integrity administration, and structural analysis for production platforms; and feasibility and revamp studies, in addition to planning activities related to the development and construction of refining, petrochemical, chemical, and fertilizer complexes.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The data demonstrated in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
